Antigen-Peptide-Transporter 2 DeficiencySymptoms, Doctors, Treatments, Advances & More
Learn About Antigen-Peptide-Transporter 2 Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Mayo Clinic-Rochester
Michael Jensen is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Jensen is rated as a Distinguished provider by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Antigen-Peptide-Transporter 2 Deficiency, Obesity, Heart Failure with Preserved Ejection Fraction (HFpEF), Gastric Bypass, and Endoscopy.
Cleveland Clinic Main Campus
Timothy Chan is a Radiation Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 31 years. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Gliomatosis Cerebri, Glioblastoma, and Brain Tumor. Dr. Chan is board certified in American Board Of Radiology, 2009.
Sylvia Santosa practices practicing medicine in Montreal, Canada. Ms. Santosa is rated as a Distinguished expert by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Antigen-Peptide-Transporter 2 Deficiency, Obesity, Isolated Hypogonadotropic Hypogonadism, and Hypogonadotropic Hypogonadism.
Summary: This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blin...